Presentation Information

[S5-3]Development of an Intranasal Therapeutic Vaccine for Cervical Cancer Leveraging the Mucosal Homing Pathway

○Rika Nakahashi1 (1. Chiba University Hospital, Human Mucosal Vaccinology (Japan))

Password required to view


Comment

To browse or post comments, you must log in.Log in